stockportfolio.pro
Indivior Pharmaceuticals, Inc. EPS (Earnings per Share) 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual earnings per share by fiscal year, computed from SEC filings.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $1.64 | +3180.0% |
| FY 2024 | $0.05 | +105.4% |
| FY 2023 | $-0.92 | -187.5% |
| FY 2022 | $-0.32 | — |
Source: Indivior Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for Indivior Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIndivior Pharmaceuticals, Inc. — frequently asked questions
What is Indivior Pharmaceuticals, Inc.'s earnings per share?
Indivior Pharmaceuticals, Inc. (INDV) reported earnings per share of $1.64 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Indivior Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.